Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights
Published in Hepatitis Weekly, August 11th, 2008
"The first half of 2008 has been a remarkably productive time at Anadys," said Steve Worland, Ph.D., President and CEO. "Through the focused efforts of our employees, we have initiated dosing in three clinical programs in six months. For hepatitis C, we commenced dosing in our Phase I clinical trial of ANA598 during the second quarter, and are happy to announce that we have now commenced...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2008-08-11)
More Articles from Hepatitis Weekly
- Imperial College London
Liver damage in hepatitis C patients could be treated with warfarin, says study - Acute Hepatitis
New acute hepatitis research from Okayama University, Medical Department discussed - Alcoholism
Reports summarize alcoholism research from S.J. Thomson and co-authors - Hepatitis
New data from V. Verma et al illuminate research in hepatitis - Hepatitis A Virus
Findings from S. Sellamuthu and co-authors broaden understanding of hepatitis A virus - Hepatitis B Virus
New hepatitis B virus research from T.T.T. Huy et al outlined - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
